|
### investigation of this event is pending and a supplemental report will be sent upon its completion.### medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
A supplemental is being submitted for completion of the investigation.Product event summary: (b)(6) was not returned for evaluation.This complaint is associated with a clinical adverse event.A review of the device history record was not performed as the reported event is not related to a manufacturing or a servicing issue.Log file analysis could not be performed since log files were not available for analysis.Of note, information provided by the site indicated that the patient subsequently died and the cause of death was unknown.Based on the available information, the device may have cause or contributed to the reported event.Per the instructions for use, death is a known potential complication associated with the implantation of a vad.There was no evidence that the patient had a history of adverse events.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.### medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|